FindTrial
Sign In

Evaluation of cholesterol medication along with blood extract in treatment of tooth disease

A Comparative Evaluation of efficacy of 1.2% atorvastatins and 1.2% rosuvastatin with PRF in intraossous alveolar defects: a randomized clinical trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/11/010358
Enrollment
80
Registered
2017-11-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: open flap debridement: open flap debridement Intervention2: atorvastatin: 1.2% atorvastatin applied once at the time of surgical intervention Intervention3: Platelet rich fibrin coated

Sponsors

Rajiv Gandhi University of Health Sciences Karnataka
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Minimum 20 permanent teeth should be present. Periodontal pocket depth > 5 mm after SRP. Intra Bony Defect >3mm on intra oral periapical radiographs

Exclusion criteria

Exclusion criteria: Systemically compromised patients and those on medications (corticosteroids/ Bisphosphonate, statin therapy) that may interfere with woundhealing. Grade II , Grade III tooth mobility. Smokers and alcoholic subjects. Pregnant and lactating women. Subjects who underwent periodontal treatment within a period of 1 year

Design outcomes

Primary

MeasureTime frame
Reduction of probing depthsTimepoint: At baseline, 3 months, 6 months and after 9 months—

Secondary

MeasureTime frame
Radiographic bone fillTimepoint: Radiographic bone fill will be checked at baseline and 9 months—

Countries

India

Contacts

Public ContactAnirban Chatterjee

THE OXFORD DENTAL COLLEGE AND HOSPITAL

dranirbanchatterjee@yahoo.com9845003721

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026